Scientists successfully control when genetically engineered non-toxic bacteria, after intravenously injected, invades cancer cells and delivers cancer-fighting drugs directly into tumors in mouse models, sparing healthy tissue, and delivering more therapy as the bacteria grow in the tumors.
Read Full Article
#CancerResearch #GeneEngineering #TargetedTherapy #PrecisionMedicine #BiomedicalInnovation
Read Full Article
#CancerResearch #GeneEngineering #TargetedTherapy #PrecisionMedicine #BiomedicalInnovation
University of Massachusetts
Research Using Non-Toxic Bacteria to Fight High-Mortality Cancers Prepares for Clinical Trials
The latest breakthrough from a team of UMass Amherst and Ernest Pharmaceutical researchers uses aspirin in its targeted drug delivery therapy.
👏4🤡1